Article Information
- Received July 17, 2012
- Revision received December 14, 2012
- Accepted January 10, 2013
- First published February 27, 2013.
- Version of record published February 27, 2013.
Author Information
Author contributions
Author contributions: K.D.M. and U.H. designed research; K.D.M. performed research; K.D.M. contributed unpublished reagents/analytic tools; K.D.M. analyzed data; K.D.M. and U.H. wrote the paper.
Disclosures
- Received July 17, 2012.
- Revision received December 14, 2012.
- Accepted January 10, 2013.
This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism to K.D.M. and U.H. We thank members of the Heberlein lab for their critical comments on the research and this manuscript; the Bloomington Stock Center, Vienna Drosophila RNAi Center, and Drosophila Genetic Resource Center for fly stocks; the TRiP at Harvard Medical School (National Institutes of Health–National Institute of General Medical Sciences R01-GM084947) for providing transgenic RNAi fly stocks; J. Veenstra for antibodies against Corazonin; R. Schuh for antibodies against Apt; and D. Montell for fly stocks.
The authors declare no competing financial interests.
- Correspondence should be addressed to either of the following Kimberly McClure, Elmhurst College, Department of Biology, 190 Prospect Avenue, Elmhurst, IL 60126, kimberly.mcclure{at}elmhurst.edu; or Ulrike Heberlein, Howard Hughes Medical Institute, Janelia Farm Research Campus, 19700 Helix Drive, Ashburn, VA, 20147, heberleinu{at}janelia.hhmi.org
Online Impact